Pulmonx Q1 2024 GAAP EPS $(0.36) Beats $(0.46) Estimate, Sales $18.854M Beat $17.893M Estimate
Author: Benzinga Newsdesk | May 01, 2024 04:39pm
Pulmonx (NASDAQ:
LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.46) by 21.74 percent. This is a 14.29 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $18.854 million which beat the analyst consensus estimate of $17.893 million by 5.37 percent. This is a 29.71 percent increase over sales of $14.535 million the same period last year.
Posted In: LUNG